Microsoft word - cox 2014 abridged advantage formulary
The Catamaran Preferred Drug List is a guide
identifying preferred brand-name medicines within select therapeutic categories. The Preferred Drug
List may not include all drugs covered by your
prescription drug benefit. Generic medicines are
available within many of the therapeutic categories
listed, in addition to categories not listed, and should
be considered as the first line of prescribing.
For benefit coverage or restrictions please check
your benefit plan document(s). This listing is revised
periodically as new drugs and new prescribing
information becomes available. It is recommended
that you bring this list of medications when you or a
covered family member sees a physician or other
QUINOLONES ANTI-INFECTIVES ANTIFUNGALS TETRACYCLINES PENICILLINS CEPHALOSPORINS ANTI-INFLAMMATORY BETA BLOCKERS AUTO-IMMUNE CARDIOVASCULAR ACE-INHIBITORS CALCIUM CHANNEL BLOCKERS ANGIOTENSIN RCPTR BLOCKER ANTI-HTN COMBINATIONS FIBRATES BILE ACID SEQUESTRANTS NITRATES & NITRITES CHOLEST ABS INHBTR/COMBO NIACIN/COMBINATIONS OMEGA-3 FATTY ACIDS ANTIHYPERLIPIDEMICS DERMATOLOGICALS TOPICAL ANTI-INFLAMMATORY ENDOCRINE CONTRACEPTIVE AGENTS NON-INSULIN HYPOGLYCEMICS BIGUANIDES BIGUAN/SULFONYLUREA COMB. TESTOSTERONE AGENTS ESTROGENS/COMBINATIONS BIGUAN/THIAZOLIDEINEDIONE DPP-4 INHIBITORS ULCER DRUGS MULTIPLE SCLEROSIS BIGUANIDE/DPP-4 COMB. SULFONYLUREAS NEUROLOGICALS GROWTH HORMONE ALZHEIMER'S DISEASE SULFONYLUREA/TZD COMB. INCRETINS ANTICONVULSANTS AMYLIN ANALOGS HEPATITIS C ANTIVIRALS ANTIHYPOGLYCEMIC AGENTS GASTROINTESTINAL INTERFERONS PROTON PUMP INHIBITORS PROTEASE INHIBITORS ANTI-INFECTIVES OPHTHALMICS ANTI-ALLERGIC AGENTS ANTI-INFLAMMATORY AGENTS ANTI-GLAUCOMA AGENTS MIGRAINE/HEADACHE CORTICOSTEROIDS/RELATED CNS STIMULANTS PSYCHOTHERAPEUTICS ATYPICAL ANTIPSYCHOTICS MISCELLANEOUS OSTEOPOROSIS BISPHOSPHONATES SNRI ANTIDEPRESSANTS SSRI ANTIDEPRESSANTS STEROID/BETA AGONIST UROLOGICALS BENIGN PRSTATC HYPRPLSIA LEUKOTRIENE RCPTR ANTGNST RESPIRATORY ANAPHYLAXIS TX AGENTS PULMONARY CORTICOSTEROIDS ERECTILE DYSFUNCTION ANTICHOLINERGICS URINARY ANTISPASMODICS ANTICHLNRGC/BETA AGONIST NASAL ANTIHISTAMINES BETA AGONISTS NASAL CORTICOSTEROIDS
Formulary Disclaimer: Coverage for some drugs may be
limited to specific dosage forms and/or strengths. The
benefit design determines what is covered and the
applicable co-payment. The medications listed on this
formulary are subject to change pursuant to the formulary management activities of Catamaran. The presence of a medication on this formulary list does not guarantee coverage. To determine the most up-to-date formulary status of your medication, please visit your member website or call member services at the number listed on your ID card.
bisoprolol fumarate/hydrochlorothiazide,
candesartan cilexetil/hydrochlorothiazide, Cialis, 10
esterified estrogens/methyltestosterone,
ipratropium bromide/albuterol sulfate, 10
methyltestosterone/esterified estrogens,
timolol maleate ophthalmic gel forming, 8
sodium sulfacetamide/sulfur cleanser, 4 Tecfidera Starter Pack, 7
Sodium Sulfacetamide/Sulfur Cleanser IN Teflaro, 1
Sodium Sulfacetamide/Sulfur IN Urea, 4 Temovate, 5
Formulary controls: Abuse of Psychotropics, and Dispensary Costs in the Incarceration Environment George (‘Bud’) Laird, Ph.D and Pratap Narayan, M.D., Fresno County Division of Correctional Health Prevalence of substance abuse/dependence in incarcerated populations: 68%. Comorbidity: 72% of inmates with mental illness have substance abuse/dependence. In this population in the jail/pr
Smoking was an exclusion criterion for controls, whereasFigure 1. Methodological Quality of Animal Trials (n=76)4 of the 21 cases were regular smokers of 2 to 10 cigarettesper day. Mean urinary excretion rates of 8-iso-PGF2␣ weresimilar in the 4 smokers (404 pg/mg of creatinine) and inthe 21 cases considered as a whole (482 pg/mg of creati-nine). Urine albumin excretion rates were not teste